Wolters Kluwer Health, a global provider of clinical technology and information solutions, has introduced significant updates to its Sentri7 Drug Diversion and Sentri7 Pharmacy solutions. The enhancements aim to optimize medication safety, streamline staff workflows, and support healthcare teams in delivering more effective patient care.
The redesigned Sentri7 Drug Diversion solution features a simplified, user-focused interface that improves the precision and speed of identifying and responding to diversion risks. The updated platform consolidates key risk indicators and actionable intelligence into a single dashboard, allowing healthcare professionals to monitor, detect, and follow up on diversion concerns more efficiently. Enhancements, such as refined HEAT scoring and trend analysis tools, enable users to identify high-risk individuals across facilities. New missing medication analysis capabilities assist nursing teams in reconciling transactions across care settings, facilitating timely interventions.
Healthcare professionals using the updated interface have reported improvements in usability, with clearer visualizations, more intuitive graphics, and greater ease in training staff. The system's scoring mechanisms automatically flag areas of concern, reducing the need for manual review and accelerating response times in potential diversion incidents.
In parallel, the updated Sentri7 Pharmacy solution introduces a patient-centered approach to medication management, emphasizing workflow efficiency, safety, and cost effectiveness. The interface now supports both individual patient rounding and broader medication surveillance across entire populations. Enhanced documentation tools enable standardized data entry and clearer performance reporting, allowing pharmacy teams to demonstrate a measurable impact using evidence-based metrics. The platform also delivers actionable performance insights, highlighting key indicators such as cost savings, departmental contributions, and patient outcomes.
Pharmacy analysts have noted that the Sentri7 updates reflect strong collaboration between Wolters Kluwer and healthcare organizations. The solutions have been commended for their adaptability and for fostering end-user engagement in product development, contributing to more effective clinical surveillance practices.
Click here to read the original press release.
